Contact
Kristen M. O'Dwyer, M.D.
View Contact & SchedulingAbout Me
Faculty Appointments
Associate Professor - Department of Medicine, Hematology/Oncology (SMD)
Associate Professor - Cancer Center - Joint
Credentials
Residency & Fellowship
Fellowship, Medical Oncology, Memorial Sloan-Kettering Cancer Center. 2006 - 2010
Residency, Internal Medicine, New York Presbyterian Hospital/Weill Cornell. 2005 - 2006
Internship, Internal Medicine, New York Presbyterian Hospital/Weill Cornell. 2004 - 2005
Internship, Pathology, National Cancer Institute/National Institute of Health. 2003 - 2004
Education
MD | University of Wisconsin Medical School-Madison. 2003
Awards
Young Investigator Award. 2016
Wilmot Cancer Research Fellowship. 2010 - 2013
Young Investigator Award. 2009 - 2010
Research
Clinical Trials
Lead Researcher: Kristen M O'Dwyer
This phase II trial studies how well inotuzumab ozogamicin and blinatumomab work in treating patients with CD22-positive B-lineage acute lymphoblastic leukemia that is newly diagnosed, has come back, or does not respond to treatment. Immunotherapy wi...
Lead Researcher: Kristen M O'Dwyer
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ...
Lead Researcher: Kristen M O'Dwyer
This phase II trial studies how well OBI-3424 works in treating patients with T-cell acute lymphoblastic leukemia that has come back (relapsed) or does not response to treatment (refractory). Drugs used in chemotherapy, such as OBI-3424, work in diff...
Publications
Journal Articles
Optimal Approach to T-cell ALL. Hematology Am Soc Hematol Educ Program
O'Dwyer KM.
2022; 2022 (1):197-205.
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Shah BD; Ghobadi A; Oluwole OO; Logan AC; Boissel N; Cassaday RD; Leguay T; Bishop MR; Topp MS; Tzachanis D; O'Dwyer KM; Arellano ML; Lin Y; Baer MR; Schiller GJ; Park JH; Subklewe M; Abedi M; Minnema MC; Wierda WG; DeAngelo DJ; Stiff P; Jeyakumar D; Feng C; Dong J; Shen T; Milletti F; Rossi JM; Vezan R; Masouleh BK; Houot R.
2021; Lancet 2021;398:491-502.
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults.
Sekeres MA; Guyatt G; Abel G; Alibhai S; Altman JK; Buckstein R; Choe H; Desai P; Erba H; Hourigan CS; LeBlanc TW; Litzow M; MacEachern J; Michaelis LC; Mukherjee S; O'Dwyer K; Rosko A; Stone R; Agarwal A; Colunga-Lozano LE; Chang Y; Hao Q; Brignardello-Petersen R.
2020; .
Ratings & Comments
At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.
Ratings
Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)
Likelihood of recommending this care provider to others
Explanations the care provider gave you about your problem or condition
Care provider's efforts to include you in decisions about your care
Concern the care provider showed for your questions or worries
Patient Comments
Good
Jan 11, 2025
Very good
Nov 24, 2024
I have a great team of doctors at the U of R
Jan 18, 2024
I would definitely recommend Dr. O'Dwyer as well as the Wilmont Cancer Center to anyone going through cancer. Best care I have ever seen!
Aug 31, 2023
Dr. O'Dwyer is excellent.....very caring and easy to talk to. Explains everything.
Aug 12, 2023
Dr. O'Dwyer always takes time to address concerns. The Lab (Blood Lab) are also always pleasant.
May 04, 2023
Good.
Apr 11, 2023
Couldn't like a doctor more than I like Dr. O'Dwyer. She instills a great deal of confidence in me concerning her skills & knowledge.
Jul 28, 2022
Excellent care.
May 25, 2022
Cannot say enough about my level of trust I have for Dr. O'Dwyer.
Feb 14, 2022